News / Events

Recent News View All News

Adial Pharmaceuticals Receives Notice of Allowance on U.S. Patent for the Treatment for Opioid Use Disorder Using AD04

January 24, 2022

Adial Pharmaceuticals to Present at the H.C. Wainwright BioConnect 2022 Conference

January 10, 2022

Recent Events View IR Calendar

H.C. Wainwright BioConnect 2022

January 10 – January 13, 2022

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings